2026-04-13T01:53:14Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1203952025-12-06T04:08:30Zcom_2072_1057col_2072_478798col_2072_478858col_2072_478916col_2072_478917col_2072_478921
RECERCAT
author
Salgado, Rocío
author
Servitje Bedate, Octavio
author
Gallardo, F. (Fernando)
author
Vermeer, Maarten H.
author
Ortiz Romero, Pablo Luis
author
Karpova, Maria B.
author
Zipser, Marie C.
author
Muniesa Montserrat, Cristina
author
Garcia-Muret, Maria P.
author
Estrach Panella, Ma. Teresa (María Teresa)
author
Salido Galeote, Marta
author
Sánchez Schmidt, Júlia
author
Herrera, Marta
author
Romagosa, Vicenç
author
Suela, Javier
author
Ferreira, Bibiana I.
author
Cigudosa, Juan Cruz
author
Barranco, Carlos
author
Serrano, Sergi
author
Dummer, Reinhard
author
Tensen, Cornelis P.
author
Solé Ristol, Francesc
author
Pujol, Ramon M.
author
Espinet Solà, Blanca
2018-03-02T09:57:27Z2018-03-02T09:57:27Z2010-042018-03-02T09:57:27Z
Mycosis fungoide (MF) patients who develop tumors or extracutaneous involvement usually have a poor prognosis with no curative therapy available so far. In the present European Organization for Research and Treatment of Cancer (EORTC) multicenter study, the genomic profile of 41 skin biopsies from tumor stage MF (MFt) was analyzed using a high-resolution oligo-array comparative genomic hybridization platform. Seventy-six percent of cases showed genomic aberrations. The most common imbalances were gains of 7q33.3q35 followed by 17q21.1, 8q24.21, 9q34qter, and 10p14 and losses of 9p21.3 followed by 9q31.2, 17p13.1, 13q14.11, 6q21.3, 10p11.22, 16q23.2, and 16q24.3. Three specific chromosomal regions, 9p21.3, 8q24.21, and 10q26qter, were defined as prognostic markers showing a significant correlation with overall survival (OS) (P=0.042, 0.017, and 0.022, respectively). Moreover, we have established two MFt genomic subgroups distinguishing a stable group (0-5 DNA aberrations) and an unstable group (>5 DNA aberrations), showing that the genomic unstable group had a shorter OS (P=0.05). We therefore conclude that specific chromosomal abnormalities, such as gains of 8q24.21 (MYC) and losses of 9p21.3 (CDKN2A, CDKN2B, and MTAP) and 10q26qter (MGMT and EBF3) may have an important role in prognosis. In addition, we describe the MFt genomic instability profile, which, to our knowledge, has not been reported earlier.
(c) Salgado, Rocío et al., 2010 info:eu-repo/semantics/openAccess
Oligonucleòtids
Genòmica
Micosi
Tumors
Marcadors genètics
Oligonucleotides
Genomics
Mycosis
Tumors
Genetic markers
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion